Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: U.K. may consolidate AER system, New York restricts DXM sales, Actavis divests oral contraceptives, homeopathic earache products warned

This article was originally published in The Tan Sheet

Executive Summary

U.K. eyes consolidating AER system; NY restricts DXM sales; Actavis divests oral contraceptives; ScriptPro simplifies NPLEx; firms warned for homeopathic earache products; tainted supplement recalls; CRN seeks more time for medical food comments; and vitamin K2 gains in popularity.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS106647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel